Dr. Lishan Aklog
the you forward quarter of good morning, Thank here. time. an our giving this business Mike, It’s you first everyone. for good to XXXX. year the of update Thanks Look in be to and taking
annual increase release the the on We Let’s quarter. That’s These commercially highlighted as XX% in tests with of a first basis fourth XXXX over press just some the highlights. a EsoGuard in were quarter increase. X,XXX XXX% a quarterly well. start performed and
substantial they represent about quarter. satellite bit the increases Test into testing We’ve samples Center in in Lucid first later. seen further, the little a XX% that the for collected We’ll of activity, dive now
were Our CheckYourFoodTube year. this and week. had DDW we gear in That EsoCheck. launched is Event is -- excellent the EsoGuard premier we gastroenterology Week that data Chicago very compelling were meeting. expanding Detection this Digestive Precancer for earlier Two had or the meeting in full presented studies program across Disease country. And and a an That’s now with
those start going with are background into I’m our diving to some story, results. for to new of the you who before
GERD, stage precancer early a company So, adenocarcinoma. highly are disease, for Lucid chronic detection, and a cancer heartburn we’re who with or Diagnostics, we’re medical gastroesophageal specifically esophageal risk commercial at diagnostics form lethal focused esophageal of patients called in prevention on cancer,
very Our this is prevent straightforward, in which deaths mission is patients. awful from at-risk cancer to
XXX% picking is middle really X per XX% in this the over it XXX flat of facts really of for -- contrast remained there, actor five-year quite prevalent the over and an increase has to most the have slide other which down, cancer. cancer, the The about decades, lethal rate the year. makes key deaths XX,XXX it is gone which with become about there is second cancers, or Just the It’s is of that you a right of bad patients it’s stage than for at consequence have accounts deaths. X% approximately and not the with is case a mortality lethal, highly a And defined even one couple less who statistic common cancer. in endoscopy and recommended, all last And opportunity well of the is It precancer esophageal last cure. stage decades that and XX% population, to mortality that. which excellent over disease detection those screening or although target early gives endoscopy. of opportunity, prevent cancer That’s up are rare one common this rate, that screening necessary examples for carries for undergo other the cancers, with recommended an unlike the one -- of
recently cancer. esophageal only societies, are equivalent test available precancer. support as Both EsoCheck tool the screening -- detection they gastroenterology through guidelines such now a the EsoCheck, alternative esophageal to early widespread cancer updated endoscopy serving of testing Our and products collectively of lead of early as biomarker and major the detection College capable tool commercially and American of EsoGuard EsoGuard form that’s first to the acceptable prevent -- Association, esophageal deaths non-endoscopic their Gastroenterological and an American and Gastroenterology for as and
opportunity market fact is on that population large screening. extremely recommended The there’s a here large, based is the that for
guidelines that for are recommended actually are So, -- number risk well at are approximately patients heartburn XX screening. million being by with are is somewhat established conservative. and chronic That
heartburn. have One the who two expanded actually the don’t patients of population symptomatic include to guidelines target
those So, nationwide $X,XXX. you’ll see, as of Medicare reflected is is with our And engagements has in that under higher. payers as payment that guidelines moderately Medicare number actually private been well. a has established
U.S. approximately margin very XX%. addressable gross a volume in billion results over The at that large market. $XX is So, total
Center, expanding. office rapidly the form the the procedure Lucid a otherwise. I’ll actual as just to satellite as test would And and tests, two mentioned. cell -- a quick in performed physicians, them primary slide model in is tests Lucid stakeholders. other reflects I in The get data care target satellite of a two the situations the practitioner, goal you We institutions. Test EsoGuard performance the the Lucid the And and physicians, of center show groups in those have EsoGuard strategy. physician’s Lucid specialists as results actually care primary separately, is by one ask at the approaches this, our collection tests test test different that to order very performance to order others Just or we would these of to And on either center, commercial nurse facility, they is bringing or
a little So, the flesh basis we bit, to XX patients nurse day. scheduled testing practitioner, regular by our the they a to can in a that have just for is a physician’s happens practitioner. schedule have that up at perform office day what on office out and nurse They each
me. the -- excuse With specialty
I Sorry, apologize. forgot I advance to the slide.
the endoscopy, a the to such increased With within their a clinician, downstream [ph] that facility. using -- or be specialists to or growing assistant surgeries, is or the different that’s other for Test by the well. model program. nurse and practice, practitioner, can model, either the looking to testing is in where purpose approach institutions somewhat satellite And institutions, Lucid with a specialty go there physician nurse own or an for work to the formed And EsoGuard as their we’re that the specialists -- garner the institutions opportunities procedure Center a
excellent Down to our results, we quarter. an commercial had
can The ago. over total here, We of steady in tests, year a increase XXX% to quarter to you first our continues a see quarter, compared and XX% the number fashion. prior increased
primary about physician by could been third And on see are number now that But the a physicians is that of procedures source proportion are slide some test stable is Two conjunction here referral the thirds and care a XX% this office the performed the institutions. these It’s there, EsoCheck about -- being their and right quarters, The being the being of volume. two distribution thirds. two practice by physician’s XX% actually at Lucid the now XX%. center over total subcollection of remain about as own pie in the personnel. you of specialists are and a in -- recent performed performed reflecting personnel. testing charts number satellite itself with And of
volume So announced that testing time geared Events. arrive last our towards events launched that’s a practitioners for Precancer nurse holding we at had group events, a our with where These are testing. we location CheckYourFoodTube scheduled Detection high
earlier event two were first firefighters with tested XXX the Antonio approximately year, The and firefighters this over was weekends. San
these we months. the orange and completed across pies remaining, of are as already have the there the of weeks expanding. blue program nine announced That the for can in have robust country. you we pipeline, the -- We’ve a is coming And events scheduled see others
about payments. and contracts comments Few
Medicare-Medicaid stable as relatively On you that proportion patients are the that actually around of see at stable XX%. are the remains can right well. side, aspects other the And
the continue on our over is payments average We are that the contracts average and contracted That’s an have we payment $X,XXX. in-network about price to the respects above Medicare XX% for charges Medicare rate a with get above to out-of-network -- all out-of-network $X,XXX. typical XX% we to of continue an based benefit. And me, average maintain that contracts price rate. contracted the rate and the Medicaid Excuse
drivers working to generating future contracting. the We’re And of hard are continue continue commercial so. we a history to and claims in-network this to drive payer do key
that XXX next entering of whom insurers really about critical into talk that commercial to have a That We And have utility, so utility is claims element in-network generating and the clinical this the part of almost clinical is payers critical far. I’ll in we’ve slide. -- data. submitted
We’re also transitioning to provider. cycle management a new revenue
will next excited so, with We’re where private our to data happen more month data in going payers. or have the facilitate to actionable we and that’s that engagement significantly
ASO, have We outside initiative also commercial a done Strategic of as the insurers. the Initiative. contracts. engage, revenue And Last space of think traditional meaningful Direct a payer is and to with the launched Contracting directly, entities self-insured, there’s employers, that other as unions this time, we we’ve others goal diagnostic in announced to opposed opportunity
have had As said, others success I with this. some
And have -- who to is are be planning to to lead side. We internal of person leading going person who this actually part I’ll are program. we the and this dedicated going hiring is also be a -- note, event that the events
secure mentioned, of I a collecting utility contracts. critical clinical to really part is and reimbursement our in-network secure data As predictable efforts
impact demonstrating a orders utility they type of test clinical It’s an on to our a specifically, the it entities test, a that physician a actually briefly, those More Just that data. decision physician has data result. means -- basically very making. is upon if medical act specific
in a and does So, positive not. confirmatory endoscopy a a test negative results test
that the far. result experience specific what here. just based so of is we’re performed tests that’s know data so, And our been have the that documenting across broadly thousands We on
the -- been completed, for and approximately review, looking written and events peer collected study prospectively forward is the That’s has given That had being pursuing, that are and that The to retrospective prospective. for submitted XXX us currently that. retrospective great collection studies firefighter is have it’s manuscript of a actually data. patients. some analysis to -- active document opportunity the data These four we’re this we’re
Registry a CLUE studies, and prospective two have multicenter that study. We Lucid the called study
of by is XXX in well. going those are each enrollment approximately those target each Our And midyear.
firefighter the particular. and We’re have a at those, the events or above both target registry enrollment in to in boost actually our been of nice
And That’s is have decision-making virtual our ongoing well then, what utility where clinical to randomized study actually for to would scenarios data is and study target. clinical used we that a a given established payers be. submitting modality their and controlled asked at and document also are physicians
about that data excited be this, first submitted can events. have of the can be that batch the very the expect retrospective submitted from data So, on we that data should that’s we coming prospective firefighter our -- of top
to that mid-year peer to that be the that with for available review will for get happen payers. engagements our us expect in-network commercial subsequently We submitted then and by will and
of Week meeting. Just a from the highlights Digestive couple Diseases
they the that we They to technical presentations. XX% rate, which VA had two -- at reported EsoCheck was faculty our success mentioned, with have, on a NPs which performed is This rate follow-up XX the success endoscopy by where veterans. excellent I As in endoscopy technical XXX% own predictive equivalent Cleveland, are one confirmatory at is which to for and spectrum The down excellent. XXX% estimated was picking -- both that be positive of screening test. XX% translates the to precancer negative which, estimated a conditions write predictive you’d really sensitivity from into a exactly where overall along cancer, it course up want value the value,
of cancer. most non-dysplastic to able esophageal earlier positive of the were abnormality. up we’re less with That’s the pickup short, of the the Notably, who difficult had treatment that important were chemotherapy or amount the pick the fact of either so up segments very four and one precancer most X short seven but lining also had we segments, gratified those. centimeters category, of because and silent about than III we’re picked There of esophagus is they who them and seven and of had abnormal detected precancer And Stage chemo them patients were -- radiation. patient longer so all that to this excited have BE. Two enter cancer
So, really VA. excellent results from the
good at Research patients We that report patients portion not approximately EsoCheck of enough improve, lead of of technical procedure quite the reported X%, esophageal previously to last presentation the with number poster to in rate, do the American proud minutes continued have which also down the sufficient cohort helped. XX% of sampling at which cells. on the who outstanding. X of the use report, is quite we’ve time not was of but The collection yields And small And expanded DNA was that the at the device already X%, number also world under for or is That quantity X,XXX of the less assay. that interval of quantity between is reported what undergo current Cancer to and DNA we’re helped. the DDW. Association This than the real the using an rate average patients data success and DNA
to in XX%, the distinction. We slides. The at DDW top presentation the the have poster push forgot excellent was
part of have last held a can solidly you X%. the the summary operations -- lab rates sufficient since operations, times early year. significantly, in quite of laboratory Finally, [indiscernible]. see at got our now took also They’re held quantity over have approximately here Turnaround we have under down plummeted the not
over I’m Dennis update. give hand things to going to financial to
